BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Xuelin Huang

Xuelin Huang contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
Methodology

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
1topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Comparison of Effect Size Measures for Mediation Analysis of Survival Outcomes with Application to the Framingham Heart Study

There is an increasing trend of research in mediation analysis for survival outcomes. Such analyses help researchers to better understand how exposure affects disease outcomes through mediators. However, due to censored observations in survival outcomes, it is not straightforward to extend mediation analysis from linear models to survival outcomes. In this article, we extend a mediation effect size measure based on $R^2$ in linear regression to survival outcomes. Due to multiple definitions of $R^2$ for survival models, we compare and evaluate five $R^2$ measures for mediation analysis. Based on extensive simulations, we recommend two $R^2$ measures with good operating characteristics. We illustrate the utility of the $R^2$-based mediation measures by analyzing the mediation effects of multiple lifestyle risk factors on the relationship between environmental exposures and time to coronary heart disease and all-cause mortality in the Framingham Heart Study.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Evidence synthesis with reconstructed survival data

We present a general approach to synthesizing evidence of time-to-event endpoints in meta-analyses of aggregate data (AD). Our work goes beyond most previous meta-analytic research by using reconstructed survival data as a source of information. A Bayesian multilevel regression model, called the "meta-analysis of reconstructed survival data" (MARS), is introduced, by modeling and integrating reconstructed survival information with other types of summary data, to estimate the hazard ratio function and survival probabilities. The method attempts to reduce selection bias, and relaxes the presumption of proportional hazards in individual clinical studies from the conventional approaches restricted to hazard ratio estimates. Theoretically, we establish the asymptotic consistency of MARS, and investigate its relative efficiency with respect to the individual participant data (IPD) meta-analysis. In simulation studies, the MARS demonstrated comparable performance to IPD meta-analysis with minor deviation from the true values, suggesting great robustness and efficiency achievable in AD meta-analysis with finite sample. Finally, we applied MARS in a meta-analysis of acute myeloid leukemia to assess the association of minimal residual disease with survival, to help respond to FDA's emerging concerns on translational use of surrogate biomarker in drug development of hematologic malignancies.

0 citations0 reviewsNo code linkedOpen access